151 related articles for article (PubMed ID: 33670297)
1. Quantum Dots as a Good Carriers of Unsymmetrical Bisacridines for Modulating Cellular Uptake and the Biological Response in Lung and Colon Cancer Cells.
Pilch J; Kowalik P; Bujak P; Nowicka AM; Augustin E
Nanomaterials (Basel); 2021 Feb; 11(2):. PubMed ID: 33670297
[TBL] [Abstract][Full Text] [Related]
2. New Unsymmetrical Bisacridine Derivatives Noncovalently Attached to Quaternary Quantum Dots Improve Cancer Therapy by Enhancing Cytotoxicity toward Cancer Cells and Protecting Normal Cells.
Pilch J; Matysiak-Brynda E; Kowalczyk A; Bujak P; Mazerska Z; Nowicka AM; Augustin E
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17276-17289. PubMed ID: 32208730
[TBL] [Abstract][Full Text] [Related]
3. c-Myc Protein Level Affected by Unsymmetrical Bisacridines Influences Apoptosis and Senescence Induced in HCT116 Colorectal and H460 Lung Cancer Cells.
Pawłowska M; Kulesza J; Augustin E
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328482
[TBL] [Abstract][Full Text] [Related]
4. Foliate-Targeting Quantum Dots-
Pilch J; Kowalik P; Kowalczyk A; Bujak P; Kasprzak A; Paluszkiewicz E; Augustin E; Nowicka AM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163186
[TBL] [Abstract][Full Text] [Related]
5. Cellular Effects of Selected Unsymmetrical Bisacridines on the Multicellular Tumor Spheroids of HCT116 Colon and A549 Lung Cancer Cells in Comparison to Monolayer Cultures.
Kulesza J; Paluszkiewicz E; Augustin E
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958764
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Antitumor Unsymmetrical Bisacridines on 3D Cancer Spheroids Growth and Viability.
Kulesza J; Pawłowska M; Augustin E
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684841
[TBL] [Abstract][Full Text] [Related]
7. pH-Responsive Drug Delivery Nanoplatforms as Smart Carriers of Unsymmetrical Bisacridines for Targeted Cancer Therapy.
Pilch J; Potęga A; Kowalczyk A; Kasprzak A; Kowalik P; Bujak P; Paluszkiewicz E; Augustin E; Nowicka AM
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678830
[TBL] [Abstract][Full Text] [Related]
8. Acid-Base Equilibrium and Self-Association in Relation to High Antitumor Activity of Selected Unsymmetrical Bisacridines Established by Extensive Chemometric Analysis.
Kosno M; Laskowski T; Frackowiak JE; Potęga A; Kurdyn A; Andrałojć W; Borzyszkowska-Bukowska J; Szwarc-Karabyka K; Mazerska Z
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807234
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cell membrane enrichment and subsequent cellular internalization of quantum dots via cell surface engineering: illuminating plasma membranes with quantum dots.
Wang HY; Hua XW; Jia HR; Liu P; Gu N; Chen Z; Wu FG
J Mater Chem B; 2016 Feb; 4(5):834-843. PubMed ID: 32263155
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cellular internalization of CdTe quantum dots mediated by arginine- and tryptophan-rich cell-penetrating peptides as efficient carriers.
Farkhani SM; Johari-Ahar M; Zakeri-Milani P; Shahbazi Mojarrad J; Valizadeh H
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1424-8. PubMed ID: 25884240
[TBL] [Abstract][Full Text] [Related]
11. Dynamics and mechanisms of quantum dot nanoparticle cellular uptake.
Xiao Y; Forry SP; Gao X; Holbrook RD; Telford WG; Tona A
J Nanobiotechnology; 2010 Jun; 8():13. PubMed ID: 20550705
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Profiles of New Unsymmetrical Bisacridine Antitumor Agents in Electrochemical and Enzymatic Noncellular Systems and in Tumor Cells.
Mieszkowska A; Nowicka AM; Kowalczyk A; Potęga A; Pawłowska M; Kosno M; Augustin E; Mazerska Z
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33915981
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-conjugated D-glucosamine- and folate- bi-functionalised InP/ZnS quantum dots for cancer cells imaging and therapy.
Ranjbar-Navazi Z; Eskandani M; Johari-Ahar M; Nemati A; Akbari H; Davaran S; Omidi Y
J Drug Target; 2018 Mar; 26(3):267-277. PubMed ID: 28795849
[TBL] [Abstract][Full Text] [Related]
14. Real time observation and kinetic modeling of the cellular uptake and removal of silicon quantum dots.
Ohta S; Inasawa S; Yamaguchi Y
Biomaterials; 2012 Jun; 33(18):4639-45. PubMed ID: 22475529
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment.
Kulkarni NS; Parvathaneni V; Shukla SK; Barasa L; Perron JC; Yoganathan S; Muth A; Gupta V
Eur J Pharm Sci; 2019 May; 133():145-159. PubMed ID: 30946965
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent approach for visually observing quantum dot uptake in living organisms.
Kim SW; Kwak JI; An YJ
Chemosphere; 2016 Feb; 144():1763-70. PubMed ID: 26524145
[TBL] [Abstract][Full Text] [Related]
17. Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide.
Zhang MZ; Yu Y; Yu RN; Wan M; Zhang RY; Zhao YD
Small; 2013 Dec; 9(24):4183-93. PubMed ID: 23828664
[TBL] [Abstract][Full Text] [Related]
18. Are quantum dots toxic? Exploring the discrepancy between cell culture and animal studies.
Tsoi KM; Dai Q; Alman BA; Chan WC
Acc Chem Res; 2013 Mar; 46(3):662-71. PubMed ID: 22853558
[TBL] [Abstract][Full Text] [Related]
19. In situ formation of viruses tagged with quantum dots.
Chen YH; Wang CH; Chang CW; Peng CA
Integr Biol (Camb); 2010 Jun; 2(5-6):258-64. PubMed ID: 20532319
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane delivery of the cell-penetrating peptide conjugated semiconductor quantum dots.
Chen B; Liu Q; Zhang Y; Xu L; Fang X
Langmuir; 2008 Oct; 24(20):11866-71. PubMed ID: 18823093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
